Modified protein and peptide pharmaceuticals
Abstract
(57) The embellished protein, summary peptide medical-supplies "partial", and a "completeness" CPT unit are used for embellishing this protein and peptide in order to change the pattern of the clearance of bioactive protein and peptide. A "completeness" CPT unit has an amino acid sequence found out by the portions from one of 112*118th of beta subunit of the human Corio gonadotropin to the 145th. At least 1 amino acid is carrying out deficiency of the "partial" CPT unit in the domains from the 118th to the 145th. The mutant of these CPT unit includes 1*5 conservative amino acid substitution which does not destroy the activity. Suitable peptide or protein embellished with this method contains various hormones and cytokine.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
147 members in 27 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 4986993 | United States of America | A | |
| 9404069 | United States of America | W |
Members147
| Document | Office | Kind | |
|---|---|---|---|
| CA2053864A1 | Canada | A1 | |
| WO9009800A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5332790A | Australia | A | |
| EP0461200A1 | European Patent Office (EPO) | A1 | |
| JPH04503606A | Japan | A | |
| EP0461200A4 | European Patent Office (EPO) | A4 | |
| US5177193A | United States of America | A | |
| CA2120358A1 | Canada | A1 | |
| WO9306844A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2864892A | Australia | A | |
| NO941186D0 | Norway | D0 | |
| NO941186L | Norway | L | |
| AU648020B2 | Australia | B2 | |
| FI941500A | Finland | A | |
| EP0607297A1 | European Patent Office (EPO) | A1 | |
| US5338835A | United States of America | A | |
| AU6747494A | Australia | A | |
| CA2160800A1 | Canada | A1 | |
| WO9424148A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6633194A | Australia | A | |
| ZA942729B | South Africa | B | |
| JPH07502166A | Japan | A | |
| US5405945A | United States of America | A | |
| CA2183564A1 | Canada | A1 | |
| CA2219948A1 | Canada | A1 | |
| WO9522340A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1878795A | Australia | A | |
| NO954188D0 | Norway | D0 | |
| EP0607297A4 | European Patent Office (EPO) | A4 | |
| FI954978A | Finland | A | |
| IL114859D0 | Israel | D0 | |
| NO954188L | Norway | L | |
| EP0695307A1 | European Patent Office (EPO) | A1 | |
| CA2173750A1 | Canada | A1 | |
| WO9605224A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3206695A | Australia | A | |
| AU667489B2 | Australia | B2 | |
| FI961600A | Finland | A | |
| NO961433D0 | Norway | D0 | |
| NO961433L | Norway | L | |
| TR199500991A2 | Türkiye | A2 | |
| AU670510B2 | Australia | B2 | |
| EP0725795A1 | European Patent Office (EPO) | A1 | |
| EP0695307A4 | European Patent Office (EPO) | A4 | |
| CN1131952A | China | A | |
| JPH08509218A | Japan | A | |
| KR960704932A | Republic of Korea | A | |
| US5585345A | United States of America | A | |
| EP0751782A1 | European Patent Office (EPO) | A1 | |
| AU6581996A | Australia | A | |
| EP0461200B1 | European Patent Office (EPO) | B1 | |
| AT148171T | Austria | T | |
| ATE148171T1 | Austria | T1 | |
| DE69029799D1 | Germany | D1 | |
| DK0461200T3 | Denmark | T3 | |
| ES2098261T3 | Spain | T3 | |
| DE69029799T2 | Germany | T2 | |
| HUT75900A | Hungary | A | |
| MX9601320A | Mexico | A | |
| JPH09505741A | Japan | A | |
| BR9506313A | Brazil | A | |
| JPH09509418A | Japan | A | |
| US5705478A | United States of America | A | |
| NZ265529A | New Zealand | A | |
| US5712122A | United States of America | A | |
| AU687053B2 | Australia | B2 | |
| EP0725795A4 | European Patent Office (EPO) | A4 | |
| EP0839831A2 | European Patent Office (EPO) | A2 | |
| US5759818A | United States of America | A | |
| AU695111B2 | Australia | B2 | |
| US5792460A | United States of America | A | |
| AU697899B2 | Australia | B2 | |
| AU703718B2 | Australia | B2 | |
| JPH11263799A | Japan | A | |
| US5958737A | United States of America | A | |
| EP0839831A3 | European Patent Office (EPO) | A3 | |
| EP0695307B1 | European Patent Office (EPO) | B1 | |
| AT187740TThis record | Austria | T | |
| ATE187740T1 | Austria | T1 | |
| DE69422169D1 | Germany | D1 | |
| US6028177A | United States of America | A | |
| ES2141229T3 | Spain | T3 | |
| IN183927B | India | B | |
| JP3045539B2 | Japan | B2 | |
| PT695307E | Portugal | E | |
| GR3032775T3 | Greece | T3 | |
| EP0751782A4 | European Patent Office (EPO) | A4 | |
| KR100281811B1 | Republic of Korea | B1 | |
| US6225449B1 | United States of America | B1 | |
| US6238890B1 | United States of America | B1 | |
| US6242580B1 | United States of America | B1 | |
| US2001007757A1 | United States of America | A1 | |
| US6306654B1 | United States of America | B1 | |
| CA2053864C | Canada | C | |
| JP2002060347A | Japan | A | |
| EP0607297B1 | European Patent Office (EPO) | B1 | |
| AT248922T | Austria | T | |
| ATE248922T1 | Austria | T1 | |
| RU2213099C2 | Russian Federation | C2 | |
| DE69233188D1 | Germany | D1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 94914152
Titles2
- German
- MODIFIZIERTE PROTEINE UND PEPTIDE ENTHALTENDE PHARMAZEUTISCHE MITTEL
- English
- MODIFIED PROTEINS AND PEPTIDES CONTAINING PHARMACEUTICAL AGENTS
Classification
- CPC, 4
- C07K14/59
- A61K38/00
- A61P5/24
- C07K2319/75
- IPC, 5
- A61K38 00
- A61K38 22
- A61K38 24
- C07K14 59
- C07K14 62